[Federal Register Volume 61, Number 51 (Thursday, March 14, 1996)]
[Notices]
[Page 10567]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-6043]



-----------------------------------------------------------------------


DEPARTMENT OF DEFENSE

Availability of Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning a Test for Quantitative Thrombin 
Time

AGENCY: U.S. Army Medical Research and Materiel Command, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent No. 5,476,771 entitled ``Test 
for Quantitative Thrombin Time'' and issued on December 19, 1995. This 
patent has been assigned to the United States Government as represented 
by the Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Staff Judge Advocate, Fort Detrick, Frederick, Maryland 21702-
5012.

FOR FURTHER INFORMATION CONTACT:
Mr. John F. Moran, Patent Attorney, (301) 619-2065 or telefax (301) 
619-7714.

SUPPLEMENTARY INFORMATION: The invention is a quantitative method for 
determining the plasma levels of thrombin-specific inhibitors which is 
based on the quantitative thrombin time using plasma dilutions, excess 
fibrinogen and thrombin. The plasma dilutions and excess fibrinogen act 
in concert to eliminate the effect that coagulopathies have on standard 
coagulation tests. The method is relatively simple and provides 
superior results to standard conventional tests. The method is suitable 
for performance in clinical hematology laboratories on a routine basis 
using commercially availability instrumentation.
Gregory D. Showalter,
Army Federal Register, Liaison Officer.
[FR Doc. 96-6043 Filed 3-13-96; 8:45 am]
BILLING CODE 3710-08-M